215 related articles for article (PubMed ID: 34955686)
1. Associations of
Guo Y; Liu Y; Yang H; Dai N; Zhou F; Yang H; Sun W; Kong J; Yuan X; Gao S
Pathol Oncol Res; 2021; 27():1609976. PubMed ID: 34955686
[No Abstract] [Full Text] [Related]
2. Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling.
Qi YJ; Jiao YL; Chen P; Kong JY; Gu BL; Liu K; Feng DD; Zhu YF; Ruan HJ; Lan ZJ; Liu QW; Mi YJ; Guo XQ; Wang M; Liang GF; Lamont RJ; Wang H; Zhou FY; Feng XS; Gao SG
PLoS Biol; 2020 Sep; 18(9):e3000825. PubMed ID: 32886690
[TBL] [Abstract][Full Text] [Related]
3. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy.
Gao S; Liu Y; Duan X; Liu K; Mohammed M; Gu Z; Ren J; Yakoumatos L; Yuan X; Lu L; Liang S; Li J; Scott DA; Lamont RJ; Zhou F; Wang H
Br J Cancer; 2021 Aug; 125(3):433-444. PubMed ID: 33981017
[TBL] [Abstract][Full Text] [Related]
4. Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population.
Du H; Luo F; Shi M; Che J; Zhu L; Li H; Hang J
Pathol Oncol Res; 2021; 27():594724. PubMed ID: 34257544
[TBL] [Abstract][Full Text] [Related]
5.
Liang G; Wang H; Shi H; Zhu M; An J; Qi Y; Du J; Li Y; Gao S
ACS Infect Dis; 2020 May; 6(5):871-881. PubMed ID: 32298082
[TBL] [Abstract][Full Text] [Related]
6. Porphyromonas gingivalis promotes the motility of esophageal squamous cell carcinoma by activating NF-κB signaling pathway.
Meng F; Li R; Ma L; Liu L; Lai X; Yang D; Wei J; Ma D; Li Z
Microbes Infect; 2019; 21(7):296-304. PubMed ID: 30763763
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
Gao SG; Yang JQ; Ma ZK; Yuan X; Zhao C; Wang GC; Wei H; Feng XS; Qi YJ
BMC Cancer; 2018 Jan; 18(1):17. PubMed ID: 29298684
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Claudin5 promotes malignant progression and radioresistance through Beclin1-mediated autophagy in esophageal squamous cell carcinoma.
Huang S; Zhang J; Li Y; Xu Y; Jia H; An L; Wang X; Yang Y
J Transl Med; 2023 Jun; 21(1):379. PubMed ID: 37303041
[TBL] [Abstract][Full Text] [Related]
9. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of
Zhang N; Liu Y; Yang H; Liang M; Wang X; Wang M; Kong J; Yuan X; Zhou F
Pathol Oncol Res; 2021; 27():1609846. PubMed ID: 34305476
[TBL] [Abstract][Full Text] [Related]
12. [The influence of Ras-associated binding protein 23 knockdown on the migration and invasion of esophageal squamous cell carcinoma cells and its mechanism].
Ma G; Liang H; Zhang RP; Sun Y
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):108-117. PubMed ID: 38418184
[No Abstract] [Full Text] [Related]
13. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
14. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma.
Chen MF; Lu MS; Hsieh CC; Chen WC
Cell Oncol (Dordr); 2021 Apr; 44(2):373-384. PubMed ID: 33201403
[TBL] [Abstract][Full Text] [Related]
15. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma.
Wang Y; Xing Q; Chen X; Wang J; Guan S; Chen X; Sun P; Wang M; Cheng Y
Curr Cancer Drug Targets; 2019; 19(9):756-763. PubMed ID: 30714525
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of B7-H6 in esophageal squamous cell carcinoma.
Zhou H; Dong J; Guo L; Wang X; Wang K; Cai X; Yang S
Sci Rep; 2019 Dec; 9(1):18122. PubMed ID: 31792298
[TBL] [Abstract][Full Text] [Related]
18. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
19. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
